Results 41 to 50 of about 24,578 (240)

Molecular pathogenesis and prognostication of "low‐grade'' and "high‐grade" endometrial stromal sarcoma

open access: yesGenes, Chromosomes and Cancer, 2020
Endometrial stromal sarcomas (ESS) are a heterogeneous group of rare mesenchymal cancers. Considerable knowledge has been gained in recent years about the molecular characteristics of these cancers, which helps to classify them in a more meaningful ...
F. Micci, S. Heim, I. Panagopoulos
semanticscholar   +1 more source

Pneumothorax presentation in endometrial sarcoma patients receiving chemotherapy: A case series

open access: yesRare Tumors, 2020
Endometrial stromal sarcomas (ESS) account for 10-15% of uterine malignancies and are classified into four categories: endometrial stromal nodule (ESN), low-grade endometrial stromal sarcoma (LG-ESS), high-grade endometrial stromal sarcoma (HG-ESS) and ...
Angela Duvalyan   +4 more
doaj   +1 more source

Primary extrauterine cystic low-grade endometrioid stromal sarcoma mimicking stromal endometriosis. A case report emphasizing the differential diagnosis and its potential local aggressive behavior

open access: yesPolish Journal of Pathology, 2020
Genital and pelvic endometriosis is a frequently encountered lesion and its importance rely on associated symptoms and its propensity for malignant transformation.
Simona Stolnicu   +4 more
doaj   +1 more source

Extrauterine Low-Grade Endometrial Stromal Sarcoma

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2005
Objective: Endometrial stromal sarcoma is a rare cancer that accounts for 0.2% or less of all female genital tract malignancies. We present a case of extrauterine low-grade endometrial stromal sarcoma arising from endometriosis, which was managed by ...
Yu-Ju Chen   +2 more
doaj   +1 more source

Histopathological study of endometrial stromal sarcomas [PDF]

open access: yes, 2018
Background: Endometrial stromal sarcomas (ESSs) are rare malignant uterine tumours comparatively affecting younger women and the mean age is 42 to 58 years.
Beigh, Ambreen   +2 more
core   +2 more sources

Progestins Related to Progesterone and Testosterone Elicit Divergent Human Endometrial Transcriptomes and Biofunctions. [PDF]

open access: yes, 2020
Progestins are widely used for the treatment of gynecologic disorders and alone, or combined with an estrogen, are used as contraceptives. While their potencies, efficacies and side effects vary due to differences in structures, doses and routes of ...
Balayan, Shayna   +8 more
core   +1 more source

Sarcoma de estroma endometrial. Estudio clinicopatológico e inmunofenotípico de 5 casos [PDF]

open access: yes, 2007
Introducción: El sarcoma de estroma endometrial uterino es un tumor muy poco frecuente con una incidencia de 0,4 -3,4 por 100.000 mujeres, comprende menos del 1% de tumores malignos ginecológicos y el 2-5% de tumores malignos uterinos, siendo el tercer ...
Llombart Bosch, Antonio   +4 more
core   +1 more source

Immunohistochemistry of endometrial stromal sarcoma

open access: yesHuman Pathology, 1991
Twenty-three cases (12 low grade, 11 high grade) of endometrial stromal sarcoma were studied with monoclonal antibodies to vimentin, keratin, desmin, muscle actin, epithelial membrane antigen, and collagen type IV, using the avidin-biotin immunoperoxidase method. Tumors were highly variable in the expression of these antigens.
Anwar Farhood   +3 more
openaire   +3 more sources

Uterine sarcoma Part II—Uterine endometrial stromal sarcoma: The TAG systematic review

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2016
Endometrial stromal tumors are rare uterine tumors (
Huann-Cheng Horng   +88 more
doaj   +1 more source

Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience. [PDF]

open access: yes, 2016
BackgroundHER2/neu overexpression and/or amplification has been widely studied in a number of solid tumors, primarily in the breast. In gynecologic neoplasms, determination of HER2/neu status has not been well studied as a predictive biomarker in anti ...
Apple, Sophia K   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy